#news #biotech JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon .JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon
badams
Mon, 01/11/2021 – 09:28

from FierceBiotech: Biotech https://ift.tt/3hZaz44